NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. Di Benedetto C, Oh J, Choudhery Z, Shi W, et al. BMC Cancer 2022;22:1056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Benedetto C, Oh J, Choudhery Z, Shi W, et al. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. BMC Cancer 2022;22:1056.
PMID: 36224576